Roche Elecsys Anti-CCP Immunoassay Catalog # 05031656160

FDA Device Recall #Z-2362-2019 — Class II — July 16, 2019

Recall Summary

Recall Number Z-2362-2019
Classification Class II — Moderate risk
Date Initiated July 16, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Roche Diagnostics Operations, Inc.
Location Indianapolis, IN
Product Type Devices
Quantity 550

Product Description

Roche Elecsys Anti-CCP Immunoassay Catalog # 05031656160

Reason for Recall

Performance issues with certain lots of the Elecsys Anti-CCP assay on the cobas e 411 analyzer; MODULAR ANALYTICS E 170 module; and cobas e 601, 602, and 801 modules with plasma samples.

Distribution Pattern

AZ CA FL HI IA IL IN KY LA MA MI MO MT NJ NY OK OR PA PR SC TX VA

Lot / Code Information

Lot # 376808 Exp 08/31/2019 Lot # 389165 Exp 09/30/2019 Anti-CCP assay: Anti-CCP Elecsys cobas e 100 The affected lots of Anti-CCP have been distributed 02/28/2019 through 07/01/2019. ***Updated 7/17/20*** Current (in-date) and future lots of both Catalog numbers are impacted. In-date lots: 443981, exp. 07/31/2020 457164, exp. 09/30/2020

Other Recalls from Roche Diagnostics Operations, Inc.

Recall # Classification Product Date
Z-1476-2026 Class II cobas pro integrated solutions with cobas c 503... Jan 20, 2026
Z-1009-2026 Class II The Elecsys Anti-TSHR immunoassay is a three-st... Nov 21, 2025
Z-0489-2025 Class II cobas HCYS, Homocysteine Enzymatic Assay, Mater... Oct 17, 2024
Z-3187-2024 Class II Creatine Kinase (CK) used on cobas c 311/501/50... Aug 15, 2024
Z-0352-2024 Class II Tina-quant D-Dimer Test System, Fibrinogen/Fibr... Oct 3, 2023

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.